Minimally invasive coronary artery surgery—A word of caution  by unknown
Transmyocardial revascularization: Mechanism of
action with carbon dioxide and holmium–yttrium-
aluminum-garnet lasers
To the Editor:
I read with interest the article titled “Transmyocardial
Laser Treatment Denervates Canine Myocardium (J Tho-
rac Cardiovasc Surg 1997;114:883-90) by Kwong and
associates. The authors concluded that laser treatment
destroys cardiac nerve fibers and that this may contribute
to the reduced angina pectoris seen clinically. This was an
elegant experiment, but conclusions from the results of
animal experiments must be complemented by observa-
tions in human beings. In the past 4 years, my colleagues
and I have carried out transmyocardial revascularization
for the relief of class IV angina, unresponsive to maximum
medical therapy and unsuitable for coronary bypass or
angioplasty, in 295 patients. A carbon dioxide laser was
used in 228 patients and a holmium–yttrium-aluminum-
garnet (YAG) laser in 67. Preinfarction angina was
present in 111 patients who did not respond to treatment,
including intravenous heparin and nitroglycerin for at
least 1 week. The operative mortality for the carbon
dioxide laser was 3.7% for patients in stable condition
(0% last year) and 12.8% for those in unstable condition.
By 1 year dipyridamole (Persantine) thallium studies
showed increased vascularity as compared with the pre-
operative state in 55% of the patients. Angina relief
progressively increased, so that by 3 months two thirds of
the patients either had no angina or class I or II angina, by
6 months 75%, and by 1 year 90%. In fact, at 1 year 40%
had no angina, 31% had class I, and 21% had class II
angina. The late mortality (12 to 48 months) was only 7%,
and the patients remained in the angina class that was
present at 1 year. With the carbon dioxide laser, it is more
difficult to create a channel through the entire thickness of
the myocardium when there is a heavy fat layer in the
epicardium. It is fascinating that in one patient in whom
no channels reached the ventricular cavity, as confirmed
by transesophageal echocardiography, the angina de-
creased to class II by 3 months; a second patient in whom
only seven channels reached the cavity had no angina 1
year later.
With the holmium-YAG laser, the operative mortality
was 4.8% for patients in stable condition and 16.7% for
those in unstable condition because of problems with low
cardiac output, myocardial infarction, and ventricular
fibrillation, which have since been overcome by changes in
the intraoperative and postoperative care. However, the
increase in perfusion seen on the thallium study was not as
marked as in the patients treated with the carbon dioxide
laser, only 40% showing improvement. In addition, al-
though by 1 year 90% of the patients treated with the
holmium-YAG laser had improved by at least two angina
classes, only 21% had no angina, 27% were in class I, and
45%, or one half, were in class II.
In light of these observations in this large series of
patients, including progressive improvement in angina
class over the first year and relief of angina despite failure
of the laser channels to reach the ventricular cavity, I
conclude that these circumstances indicate an ongoing
process over the first year, stimulated by the interaction of
the laser with the myocardial tissue. This favors a mech-
anism of vascular neogenesis, as well as the development
of connections between preexisting intramyocardial col-
laterals, which could improve the distribution of blood
supply. The reptilian theory would not apply when no
channels or very few reached the ventricular cavity. In
addition, there is conflicting evidence about the patency of
the channels from animal experiments, as well as from
human postmortem examinations. Furthermore, if dener-
vation is the primary factor, it should have an immediate
effect that would be maintained at a constant level
throughout the year, or possibly even decline somewhat.
To the contrary, my associates and I warn all our patients
that they will still have angina for some time after the
operative procedure, but that it will gradually and slowly
decrease in frequency and severity. Finally, the differences
in results between the two lasers warn us that various
energy sources do not necessarily have the same effect on
myocardial tissue. Hence all new techniques will have to
be judged by results observed over time.
Allan M. Lansing, MD, PhD
Director, The Heart Institute
Audubon Hospital
Louisville, KY 40217
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Minimally invasive coronary artery surgery—A
word of caution
To the Editor:
Reardon and colleagues1 succinctly outlined a variety of
concerns relating to minimally invasive coronary artery
bypass surgery. Along with recognizing the pressure of the
media and company sales representatives, the authors
listed four specific concerns: (1) the accuracy and patency
of the anastomosis; (2) issues of incomplete revasculariza-
tion; (3) ability to teach the procedure to residents; and
(4) long-term outcome.
The authors concluded, however, that “on the basis of
our experience, the procedure does not seem to allow
comparable accuracy and anastomotic patency for the
community cardiac surgeon.” Indeed, it is an excellent
essay. However, to imply that “community cardiac sur-
geons” should not perform minimally invasive cardiac
procedures is an unfortunate choice of words, which has
both professional and medical-legal implications.
For example, Lehigh Valley Hospital in Allentown,
Pennsylvania, is a tertiary community hospital in which
1200 cardiac operations are performed per year. Our
program was one of the first to perform minimally invasive
directed coronary artery bypass (MIDCAB), Heartport
procedures (Heartport, Inc., Redwood City, Calif.), tho-
racoscopic harvesting of the internal thoracic artery, en-
doscopic harvesting of the saphenous vein, and robotic
assisted surgery. For each procedure, our surgeons
worked on animal models in our own laboratories, as well
as attending appropriate continuing medical education
accredited courses. We have complete follow-up on out-
comes and participate in several databases. In addition,
Pennsylvania is a “report card state,” in which all of the
cardiac surgeons’ data are publicly scrutinized.
The Baylor group’s conclusion not only may be inter-
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preted as academic snobbery divisive to our profession,
but also could open the door for malpractice attorneys to
use this inaccurate conclusion against “community sur-
geons” who are, in fact, well trained and suited to perform
these minimally invasive procedures.
I believe their conclusion should have been that sur-
geons and institutions lacking an adequate volume of
experience, laboratory facilities for training, or a system of
appropriate follow-up and clinical analysis should not
perform these types of procedures.
My father always told me that I should choose my words
carefully so that they could not come back and bite me.
The Baylor group could learn from this advice, since it is
my understanding that the Methodist Hospital in Houston
is, indeed, a “community hospital.”
Raymond L. Singer, MD
Associate Chief
Division of Cardiothoracic Surgery
Lehigh Valley Hospital
1240 S. Cedar Crest Blvd., Suite 308
Allentown, PA 18103
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Air embolism with intraaortic balloon
counterpulsation during cardiopulmonary bypass
To the Editor:
The recommendation in the recent letter by Mulay and
associates1 to maintain intraaortic balloon (IAB) counter-
pulsation during the entire period of cardiopulmonary
bypass (CPB) should be qualified with a word of caution:
cases of significant air embolism have been reported if the
aorta is opened (as it is for cannulation) at the onset of
IAB deflation.2, 3 In their letter, the authors noted that
they temporarily stop the IAB pump when clamping or
unclamping the aorta; on the basis of the previously
reported cases, we believe the IAB should also be turned
off with any aortotomy or when the arterial perfusion or
cardioplegia cannulas or vents are being inserted or
removed. It is particularly important to turn the IAB off if
a period of circulatory arrest is used, as noted by Mills and
Morris.4 The generally accepted technique of momen-
tarily lowering CPB blood flow when applying the aortic
crossclamp or removing the cardioplegia cannula or as-
cending aortic vent will lower blood pressure in the aorta
and may favor air entry with IAB deflation. Although this
mechanism of arterial air embolism may be rare, the
potential for sucking a relatively large volume (up to 40
cc) of room air into the ascending aorta during CPB is real
and can be minimized by stopping the IAB when surgical
maneuvers require that the aorta be opened. This word of
caution should not detract from the message in the
excellent letter of Mulay and associates1 outlining the
benefits of pulsatility during CPB.
Mark Kurusz, CCP
Scott D. Lick, MD
Vincent R. Conti, MD
Department of Surgery
Division of Cardiothoracic Surgery
The University of Texas Medical Branch
Galveston, TX 77555-0528
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Reply to the Editor:
I thank Kurusz, Lick, and Conti for highlighting the
potential dangers of air embolism with the use of the
intraaortic balloon (IAB). I agree with their comments
regarding the suction generated by deflation of the IAB.
Fortunately, my colleagues and I have not had such
incidents in the past 10 years and, like the authors, would
recommend that the IAB be turned off temporarily while
the aortic cannulas used for cardioplegia and bypass are
being inserted or removed. Temporary cessation of bal-
looning lowers blood pressure while the aortic clamps are
being applied. We have not used the IAB in any of the
patients who had circulatory arrest. We would, however,
agree with the suggestion that the IAB should be left
deflated during the total circulatory arrest period. Full
recirculation and deairing of the aorta should be effected
before the IAB is used while the patient is being re-
warmed. This is an important message for those using
continued IAB counterpulsation during cardiopulmonary
bypass.
R. Unnikrishnan Nair, MS, FRCS
Department of Cardiothoracic Surgery
Yorkshire Heart Centre
Leeds General Infirmary
Great George St.
Leeds LS1 3EX, United Kingdom
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